DK0811001T3 - Benzothiazindioxider som endothelinantagonister - Google Patents

Benzothiazindioxider som endothelinantagonister

Info

Publication number
DK0811001T3
DK0811001T3 DK96903708T DK96903708T DK0811001T3 DK 0811001 T3 DK0811001 T3 DK 0811001T3 DK 96903708 T DK96903708 T DK 96903708T DK 96903708 T DK96903708 T DK 96903708T DK 0811001 T3 DK0811001 T3 DK 0811001T3
Authority
DK
Denmark
Prior art keywords
endothelin
endothelin antagonists
preparation
benzothiazine dioxides
dioxides
Prior art date
Application number
DK96903708T
Other languages
Danish (da)
English (en)
Inventor
Annette Marian Doherty
Jeremy John Edmunds
Kent Alan Berryman
Amy Mae Bunker
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0811001T3 publication Critical patent/DK0811001T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Dental Preparations (AREA)
  • Polyesters Or Polycarbonates (AREA)
DK96903708T 1995-02-21 1996-01-26 Benzothiazindioxider som endothelinantagonister DK0811001T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/393,143 US5599811A (en) 1995-02-21 1995-02-21 Benzothiazine dioxides as endothelin antagonists
PCT/US1996/001093 WO1996026195A1 (en) 1995-02-21 1996-01-26 Benzothiazine dioxides as endothelin antagonists

Publications (1)

Publication Number Publication Date
DK0811001T3 true DK0811001T3 (da) 2002-02-18

Family

ID=23553452

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96903708T DK0811001T3 (da) 1995-02-21 1996-01-26 Benzothiazindioxider som endothelinantagonister

Country Status (27)

Country Link
US (1) US5599811A (ja)
EP (1) EP0811001B1 (ja)
JP (1) JPH11501013A (ja)
KR (1) KR19980702358A (ja)
CN (1) CN1071327C (ja)
AT (1) ATE207911T1 (ja)
AU (1) AU720036B2 (ja)
BG (1) BG62613B1 (ja)
CA (1) CA2211027A1 (ja)
CZ (1) CZ294412B6 (ja)
DE (1) DE69616515T2 (ja)
DK (1) DK0811001T3 (ja)
EE (1) EE03564B1 (ja)
ES (1) ES2167544T3 (ja)
FI (1) FI973380A (ja)
GE (1) GEP20001969B (ja)
HU (1) HUP9800273A3 (ja)
NO (1) NO308897B1 (ja)
NZ (1) NZ302116A (ja)
PL (1) PL321866A1 (ja)
PT (1) PT811001E (ja)
RO (1) RO116898B1 (ja)
RU (1) RU2164225C2 (ja)
SK (1) SK284275B6 (ja)
UA (1) UA47424C2 (ja)
WO (1) WO1996026195A1 (ja)
ZA (1) ZA961342B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US5945448A (en) * 1995-06-02 1999-08-31 Shionogi & Co., Ltd. Brain edema inhibitor
US5804585A (en) * 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US6432994B1 (en) 1997-04-28 2002-08-13 Texas Biotechnology Corporation Sulfonamides for treatment of endothelin-mediated disorders
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
CA2295239A1 (en) 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
PL338983A1 (en) * 1997-09-05 2000-12-04 Warner Lambert Co Some dioxides of benzothiazine as antagonists of endothelin and methods of obtaining them
GB2337048B (en) * 1998-05-05 2000-06-28 Warner Lambert Co 2,1,3-Benzothiadiazole containing endothelin antagonists
WO2001091736A2 (en) * 2000-05-31 2001-12-06 Warner-Lambert Company Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
US20020115661A1 (en) * 2000-12-07 2002-08-22 Keller Laurence Harvey Method for treating chronic obstructive pulmonary disease
BRPI0709950A2 (pt) * 2006-04-13 2011-08-02 Actelion Pharmaceuticals Ltd uso de bosentan na preparação de um medicamento para o tratamento de fibrose pulmonar idiopática em estágio precoce e uso de antagonista do receptor endotelin
FR2942797B1 (fr) * 2009-03-03 2011-04-29 Pf Medicament Derives de benzothiazines, leur preparation et leur application a titre de medicaments
US10865201B2 (en) * 2016-09-12 2020-12-15 Valo Health, Inc. Bicyclic compounds useful as GPR120 modulators
CN114671827B (zh) * 2020-12-24 2024-09-20 杭州百新生物医药科技有限公司 邻苯甲酰磺酰亚胺类衍生物及其应用
CN112521384B (zh) * 2021-01-13 2021-11-02 湖北大学 溶剂热一锅法合成苯并噻嗪并环戊二烯衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237473A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltende arzneimittel
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
JPH0441483A (ja) * 1990-06-07 1992-02-12 Tanabe Seiyaku Co Ltd ベンゾチアジン誘導体及びその製法
RU2125980C1 (ru) * 1991-11-05 1999-02-10 Смитклайн Бичам Корпорейшн Антагонисты эндотелиновых рецепторов, фармкомпозиция, способ их получения, способ подавления эндотелиновых рецепторов
US5389620A (en) * 1993-08-18 1995-02-14 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives

Also Published As

Publication number Publication date
UA47424C2 (uk) 2002-07-15
ZA961342B (en) 1996-08-26
HUP9800273A3 (en) 1999-09-28
DE69616515T2 (de) 2002-05-16
WO1996026195A1 (en) 1996-08-29
CZ294412B6 (cs) 2004-12-15
BG101867A (en) 1998-10-30
NO308897B1 (no) 2000-11-13
KR19980702358A (ko) 1998-07-15
AU720036B2 (en) 2000-05-18
NO973822D0 (no) 1997-08-20
ATE207911T1 (de) 2001-11-15
RU2164225C2 (ru) 2001-03-20
CN1071327C (zh) 2001-09-19
CZ260797A3 (cs) 1998-06-17
ES2167544T3 (es) 2002-05-16
GEP20001969B (en) 2000-03-05
FI973380A (fi) 1997-08-20
MX9706024A (es) 1997-11-29
CA2211027A1 (en) 1996-08-29
AU4770396A (en) 1996-09-11
NZ302116A (en) 1998-06-26
NO973822L (no) 1997-08-21
SK114697A3 (en) 1998-08-05
PT811001E (pt) 2002-04-29
EE03564B1 (et) 2001-12-17
HUP9800273A2 (hu) 1999-07-28
CN1180351A (zh) 1998-04-29
EE9700147A (et) 1997-12-15
RO116898B1 (ro) 2001-07-30
US5599811A (en) 1997-02-04
DE69616515D1 (de) 2001-12-06
JPH11501013A (ja) 1999-01-26
SK284275B6 (sk) 2004-12-01
EP0811001A1 (en) 1997-12-10
EP0811001B1 (en) 2001-10-31
BG62613B1 (bg) 2000-03-31
PL321866A1 (en) 1997-12-22
FI973380A0 (fi) 1997-08-18

Similar Documents

Publication Publication Date Title
DK0811001T3 (da) Benzothiazindioxider som endothelinantagonister
DK1094816T3 (da) Biphenylsulfonamider som dobbelte angiotensin-endothelin-receptorantagonister
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
EA200100972A1 (ru) Новые соединения и композиции как ингибиторы протеаз
DE69725825D1 (de) 5-HT1F-Agonisten
FI973221A (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DK0584290T3 (da) Endothelinantagonister
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
NO20021503L (no) Kinazolinoner
MY116277A (en) Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
NO20002408L (no) 5-HT1F antagonister
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya